TRH Cross 2% is a viscosupplementing agent containing 2% cross-linked hyaluronic acid. It is used for intra-articular administration (directly into the joint) to improve the viscoelastic properties of the synovial fluid. This leads to: • Reduction of pain in the knee joint • Improvement of joint mobility • Slowing the progression of osteoarthritis

⸻ Main features:

• Concentration: 2% hyaluronic acid

• Origin: Usually biosynthetic, with a high degree of purification

• Form: Sterile pre-filled syringe

• Volume: 2 ml

• Application: Single use

• Technology: Cross-linked hyaluronic acid – provides longer action in the joint

⸻ Indications: • Osteoarthritis (gonarthrosis) – mainly in the knee joint

• Degenerative joint diseases

• Joint pain and stiffness caused by reduced quantity/quality of synovial fluid

⸻ Advantages:

• Longer lasting effect compared to regular hyaluronic acid

• Fewer injections

• Improvement in quality of life and motor activity + European product: All ingredients we use are 100% European in origin and the products are manufactured entirely in the factory in the north of Spain.
Wide range: We offer viscosupplements of different concentrations, so doctors can choose what best suits their needs and way of working.

• HA of non-animal origin + SARE Technology®: we have our own crosslinking technology with innovative capabilities, superior to other products on the market in aspects such as biointegration, low endotoxin content, elasticity and viscosity.